BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24614921)

  • 41. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance.
    Lautner-Csorba O; Gézsi A; Semsei AF; Antal P; Erdélyi DJ; Schermann G; Kutszegi N; Csordás K; Hegyi M; Kovács G; Falus A; Szalai C
    BMC Med Genomics; 2012 Sep; 5():42. PubMed ID: 23021489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia.
    Schotte D; Akbari Moqadam F; Lange-Turenhout EA; Chen C; van Ijcken WF; Pieters R; den Boer ML
    Leukemia; 2011 Sep; 25(9):1389-99. PubMed ID: 21606961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
    Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
    Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment.
    Kotur N; Lazic J; Ristivojevic B; Stankovic B; Gasic V; Dokmanovic L; Krstovski N; Milosevic G; Janic D; Zukic B; Pavlovic S
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia.
    Zhou Y; Wang J; Lu X; Song X; Ye Y; Zhou J; Ying B; Wang L
    J Mol Neurosci; 2013 Mar; 49(3):594-9. PubMed ID: 23015298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.
    Franca R; Rebora P; Bertorello N; Fagioli F; Conter V; Biondi A; Colombini A; Micalizzi C; Zecca M; Parasole R; Petruzziello F; Basso G; Putti MC; Locatelli F; d'Adamo P; Valsecchi MG; Decorti G; Rabusin M
    Pharmacogenomics J; 2017 Jan; 17(1):4-10. PubMed ID: 26644204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
    Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
    Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A semantics-oriented computational approach to investigate microRNA regulation on glucocorticoid resistance in pediatric acute lymphoblastic leukemia.
    Chen H; Zhang D; Zhang G; Li X; Liang Y; Kasukurthi MV; Li S; Borchert GM; Huang J
    BMC Med Inform Decis Mak; 2018 Jul; 18(Suppl 2):57. PubMed ID: 30066657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
    Ultimo S; Martelli AM; Zauli G; Vitale M; Calin GA; Neri LM
    J Cell Physiol; 2018 Aug; 233(8):5642-5654. PubMed ID: 29154447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.
    Boni V; Zarate R; Villa JC; Bandrés E; Gomez MA; Maiello E; Garcia-Foncillas J; Aranda E
    Pharmacogenomics J; 2011 Dec; 11(6):429-36. PubMed ID: 20585341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
    Rashed WM; Hamza MM; Matboli M; Salem SI
    Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-resolution melting (HRM) analysis for the detection of single nucleotide polymorphisms in microRNA target sites.
    Lin PC; Liu TC; Chang CC; Chen YH; Chang JG
    Clin Chim Acta; 2012 Jul; 413(13-14):1092-7. PubMed ID: 22445829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between the
    Cardoso de Carvalho D; Pereira Colares Leitão L; Mello Junior FAR; Vieira Wanderley A; Souza TP; Borges Andrade de Sá R; Cohen-Paes A; Rodrigues Fernandes M; Santos S; Salim Khayat A; Pimentel de Assumpção P; Pereira Carneiro Dos Santos N
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32992962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
    Kim YK; Kim B; Kim VN
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.
    Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):589-595. PubMed ID: 28719513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA 146a Polymorphisms and Expression in Indian Children with Acute Lymphoblastic Leukemia.
    Jemimah Devanandan H; Venkatesan V; Scott JX; Magatha LS; Durairaj Paul SF; Koshy T
    Lab Med; 2019 Jul; 50(3):249-253. PubMed ID: 30576465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
    Cunningham L; Aplenc R
    Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.
    Schotte D; Chau JC; Sylvester G; Liu G; Chen C; van der Velden VH; Broekhuis MJ; Peters TC; Pieters R; den Boer ML
    Leukemia; 2009 Feb; 23(2):313-22. PubMed ID: 18923441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
    Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
    Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.